| ORGANOGENESIS HLDGS |
| USA |
| Gesundheit |
| US68621F1021 / A2PA31 |
| 2PQ (Frankfurt) / ORGO (NASDAQ) |
| FRA:2PQ, ETR:2PQ, 2PQ:GR, NASDAQ:ORGO |
| - |
| https://organogenesis.com.. |
|
Organogenesis Holdings Inc. is a prominent entity in the biotechnology field, engaged in the development, manufacture, and services related to regenerative medicine products. The company's primary focus is on products that help solve complex medical ..
>Volltext.. |
| 264.67 Mio. EUR |
| 364.67 Mio. EUR |
| 446.71 Mio. EUR |
| 38.86 Mio. EUR |
| 2.36 Mio. EUR |
| -0.13 EUR |
| 61.5 Mio. EUR |
| 79.93 Mio. EUR |
| 26.69 Mio. EUR |
| 1.21 |
| 5.06% |
| - |
| - |
| - |
| - |
| - |
| ORGANOGENESIS |
| 07.08.26 |
|